268 related articles for article (PubMed ID: 9187908)
1. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
[TBL] [Abstract][Full Text] [Related]
2. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
Lee T; Suh HJ; Lee HJ; Lee JE
J Urol; 2005 Sep; 174(3):1084-7. PubMed ID: 16094064
[TBL] [Abstract][Full Text] [Related]
4. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
Eller DA; Austin PF; Tanguay S; Homsy YL
Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
[TBL] [Abstract][Full Text] [Related]
5. Oxybutynin, desmopressin and enuresis.
Nevéus T
J Urol; 2001 Dec; 166(6):2459-62. PubMed ID: 11696812
[TBL] [Abstract][Full Text] [Related]
6. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
Wolfish NM; Barkin J; Gorodzinsky F; Schwarz R
Scand J Urol Nephrol; 2003; 37(1):22-7. PubMed ID: 12745738
[TBL] [Abstract][Full Text] [Related]
7. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Radvanska E; Kovács L; Rittig S
J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children.
Yap HK; Chao SM; Tan AY; Murugasu B; Ong EK; Low EH
J Paediatr Child Health; 1998 Apr; 34(2):151-3. PubMed ID: 9588639
[TBL] [Abstract][Full Text] [Related]
9. Functional bladder capacity as predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis.
Hamano S; Yamanishi T; Igarashi T; Ito H; Murakami S
Eur Urol; 2000 Jun; 37(6):718-22. PubMed ID: 10828674
[TBL] [Abstract][Full Text] [Related]
10. Long-term home studies of water balance in patients with nocturnal enuresis.
Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
[TBL] [Abstract][Full Text] [Related]
12. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
Martín-Crespo R; Luque R
Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
[TBL] [Abstract][Full Text] [Related]
13. Older pharmacologic therapy for nocturnal enuresis.
Rushton HG
Clin Pediatr (Phila); 1993 Jul; Spec No():10-3. PubMed ID: 8039332
[TBL] [Abstract][Full Text] [Related]
14. [An update on clinical and therapeutic aspects of nocturnal enuresis].
Chiozza ML
Pediatr Med Chir; 1997; 19(5):385-90. PubMed ID: 9493232
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for nocturnal enuresis with desmopressin and an alarm device.
Bradbury M
Scand J Urol Nephrol Suppl; 1997; 183():61-3. PubMed ID: 9165611
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of treatments for nocturnal enuresis in a heterogeneous population.
Schulman SL; Colish Y; von Zuben FC; Kodman-Jones C
Clin Pediatr (Phila); 2000 Jun; 39(6):359-64. PubMed ID: 10879938
[TBL] [Abstract][Full Text] [Related]
17. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis.
Yeung CK; Chiu HN; Sit FK
J Urol; 1999 Sep; 162(3 Pt 2):1049-54; discussion 1054-5. PubMed ID: 10458430
[TBL] [Abstract][Full Text] [Related]
18. Italian multicentre open trial on DDAVP spray in nocturnal enuresis.
Chiozza ML; del Gado R; di Toro R; Ferrara P; Fois A; Giorgi P; Giovannini M; Rottoli A; Segni G; Biraghi M
Scand J Urol Nephrol; 1999 Feb; 33(1):42-8. PubMed ID: 10100363
[TBL] [Abstract][Full Text] [Related]
19. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders].
De Grazia E; Cimador M
Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
Ezodin N; Sarouei M; Khademlo M; Milani SH; Yousefi S; Mohammadjafari H
Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
